Pattern recognition receptors

Japanese Journal of Clinical Immunology

Volumn 34, Issue 5, 2011, Pages 329-345

  Hayashi, Takaya ^a   Nakamura, Tohru ^a   Takaoka, Akinori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Autoinflammatory diseases; IL 1 ; Inflammasome; Inflammatory cytokines; NF B; PRRs

Indexed keywords

PATTERN RECOGNITION RECEPTOR;

AUTOINFLAMMATORY DISEASE; DISEASE ASSOCIATION; INNATE IMMUNITY; REVIEW;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUTOIMMUNITY; CARRIER PROTEINS; CYTOKINES; CYTOSKELETAL PROTEINS; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

EID: 80455173675     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.34.329     Document Type: Review

References (91)

1. Himanshu K, Taro K, Shizuo A.: Pathogen Recognition by Innate Immune System. Int Rev Immunol, 30: 16-34, 2011.
2. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P.: Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 32(4): 157-164, 2011.
3. Seth LM, Anna S, Ivona A, Daniel LK.: Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease. Annu Rev Immunol. 27: 621-668, 2009.
4. Miller SI, Ernst RK, Bader MW.: LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol, 3(1): 36-46, 2005.
5. Chnang S, Dolganiuc A, Szabo G.: Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol, 82(3): 479-487, 2007.
6. O'Neill LA.: When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity, 29(1): 12-20, 2008.
7. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW.: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory scyncytial virus. Nat Immunol, 1(5): 398-401, 2000.
8. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR.: Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA. 99(4): 2281-2286, 2002.
9. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, Wagner H, Kirschning CJ, Ter Meulen V, Schneider-Schaulies S.: Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol. 76(17): 8729-8736, 2002.
10. Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, Morii E, Aozasa K, Kawai T, Akira S.: Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA virus. Immunity. 27(2): 240-252, 2007.
11. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, Dermody TS, Fujita T, Akira S.: Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-indubible gene-I and melanoma differentiation-associated gene 5. J Exp Med. 205(7): 1601-1610, 2008.
12. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reise Sousa C, Matsuura Y, Fujita T, Akira S.: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441(7087): 101-105, 2006.
13. Foy E, Li K, Sumpter R Jr, Loo YM, Johnson CL, Wang C, Fish PM, Yoneyama M, Fujita T, Lemon SM, Gale M Jr.: Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci USA. 102(8): 2986-2991, 2005.
14. Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, Barchet W, Coch C, Janke M, Mihailovic A, Wardle G, Juranek S, Kato H, Kawai T, Poeck H, Fitzgerald KA, Takeuchi O, Akira S, Tuschl T, Latz E, Ludwig J, Hartmann G.: Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity. 31(1): 25-34, 2009.
15. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M Jr.: Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA. 104(2): 582-587, 2007.
16. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O.: LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA. 107(4): 1512-1517, 2010.
17. Hayakawa S, Shiratori S, Yamato H, Kameyama T, Kitatsuji C, Kashigi F, Goto S, Kameoka S, Fujikura D, Yamada T, Mizutani T, Kazumata M, Sato M, Tanaka J, Asaka M, Ohba Y, Miyazaki T, Imamura M, Takaoka A.: ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat Immunol. 12(1): 37-44, 2011.
18. Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, König M, Kalinke U, Pasparakis M, Tschopp J.: TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity. 28(5): 651-661, 2008.
19. Zhao T, Yang L, Sun Q, Arguello M, Ballard DW, Hiscott J, Lin R.: The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol. 8(6): 592-600, 2007.
20. Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G.: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 10(3): 241-247, 2009.
21. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, Bailly-Maitre B, Volkmann N, Hanein D, Rouiller I, Reed JC.: Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell. 25(5): 713-724, 2007.
22. Kufer TA, Sansonetti PJ.: NLR functions beyond pathogen recognition. Nat Immunol. 12(2): 121-128, 2011.
23. Kinoshita T, Wang Y, Hasegawa M, Imamura R, Suda T.: PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. J Biol Chem. 280(23): 21720-21725, 2005.
24. Imamura R, Wang Y, Kinoshita T, Suzuki M, Noda T, Sagara J, Taniguchi S, Okamoto H, Suda T.: Anti-inflammatory activity of PYNOD and its mechanism in humans and mice. J Immunol. 184(10): 5874-5884, 2010.
25. Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, Body-Malapel M, Inohara N, Núñez G. : RIP2/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol. 178(4) : 2380-2386, 2007.
26. Hsu LC, Ali SR, McGillivray S, Tseng PH, Mariathasan S, Humke EW, Eckmann L, Powell JJ, Nizet V, Dixit VM, Karin M. : A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci USA. 105(22) : 7803-7808, 2008.
27. Osorio F, Reise Sousa C. : Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity. 34(5) : 651-664, 2011.
28. Kerrigan AM, Brown GD. : Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs. Immunol Rev. 234(1) : 335-352, 2010.
29. Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, Förster I, Ruland J. : Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature. 442(7103) : 651-656, 2006.
30. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. : C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity. 26(5) : 605-616, 2007.
31. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB. : Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol. 10(10) : 1081-1088, 2009.
32. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SC, Geijtenbeek TB. : Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol. 10(2) : 203-213, 2009.
33. Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, Hornung V, Vogel SN, Szomolanyi-Tsuda E, Fitzgerald KA. : The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol. 11(5) : 395-402, 2010.
34. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, Fitzgerald KA, Paludan SR, Bowie AG. : IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 11(11) : 997-1004, 2010.
35. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T. : DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 448(7152) : 501-505, 2007.
36. DeFilippis VR, Alvarado D, Sali T, Rothenburg S, Früh K. : Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J Virol. 84(1) : 585-598, 2010.
37. Farasat S, Aksentijevich I, Toro JR. : Autoinflammatory diseases : clinical and genetic advances. Arch Dermatol. 144(3) : 392-402, 2008.
38. Kanneganti TD, Lamkanfi M, Núñez G. : Intracellular NOD-like receptors in host defense and disease. Immunity. 27(4) : 549-559, 2007.
39. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, van Bruggen R, Tschopp J. : Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem. 55(5) : 443-452, 2007.
40. Elinav E, Strowig T, Henao-Mejia J, Flavell RA. : Regulation of the antimicrobial response by NLR proteins. Immunity. 34(5) : 665-679, 2011.
41. Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, Núñez G. : Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity. 26(4) : 433-443, 2007.
42. Ichinohe T, Pang IK, Iwasaki A. : Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol. 11(5) : 404-410, 2010.
43. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. : Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 11(2) : 136-140, 2010.
44. Saïd-Sadier N, Padilla E, Langsley G, Ojcius DM. : Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PLoS One. 5(4) : e10008, 2010.
45. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. : Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 29(3) : 301-305, 2001.
46. Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, Cortis E, Teillac-Hamel D, Fischer A, de Saint Basile G. : Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet. 71(1) : 198-203, 2002.
47. Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, Stein L, Russo R, Goldsmith D, Dent P, Rosenberg HF, Austin F, Remmers EF, Balow JE Jr, Rosenzweig S, Komarow H, Shoham NG, Wood G, Jones J, Mangra N, Carrero H, Adams BS, Moore TL, Schikler K, Hoffman H, Lovell DJ, Lipnick R, Barron K, O'Shea JJ, Kastner DL, Goldbach-Mansky R. : De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID) : a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 46(12) : 3340-3348, 2002.
48. Aksentijevich I, D Putnam C, Remmers EF, Mueller JL, Le J, Kolodner RD, Moak Z, Chuang M, Austin F, Goldbach-Mansky R, Hoffman HM, Kastner DL. : The clinical continuum of cryopyrinopathies : novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 56(4) : 1273-1285, 2007.
49. Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, Derfalvi B, Benjaponpitak S, Vesely R, Sauvain MJ, Oertle S, Allen R, Morgan G, Borkhardt A, Hill C, Gardner-Medwin J, Fischer A, de Saint Basile G. : Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood. 103(7) : 2809-2815, 2004.
50. Gattorno M, Tassi S, Carta S, Delfino L, Ferlito F, Pelagatti MA, D'Osualdo A, Buoncompagni A, Alpigiani MG, Alessio M, Martini A, Rubartelli A. : Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum. 56(9) : 3138-3148, 2007.
51. Bernot A, Clepet C, Dasilva C, Devaud C, Petit JL, Caloustian C, Cruaud C, Samson D, Pulcini F, Weissenbach J, Heilig R, Notanicola C, Domingo C, Rozenbaum M, Benchetrit E, Topaloglu R, Dewalle M, Dross C, Hadjari P, Dupont M, Demaille J, Touitou I, Smaoui N, Nedelec B, Méry JP, Chaabouni H, Delpech M, Grateau G. : A candidate gene for familial Mediterranean fever. Nat Genet. 17(1) : 25-31, 1997.
52. Tidow N, Chen X, Müller C, Kawano S, Gombart AF, Fischel-Ghodsian N, Koeffler HP. : Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood. 95(4) : 1451-1455, 2000.
53. Masumoto J, Taniguchi S, Sagara J. : Pyrin N-terminal homology domain- and caspase recruitment domain-dependent oligomerization of ASC. Biochem Biophys Res Commun. 280(3) : 652-655, 2001.
54. Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, Kastner DL. : The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA. 103(26) : 9982-9987, 2006.
55. Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, Grütter C, Grütter M, Tschopp J. : The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ. 14(8) : 1457-1466, 2007.
56. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, Kastner DL. : Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 11(3) : 591-604, 2003.
57. Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I, Taniguchi S, Sagara J, Fernandes-Alnemri T, Alnemri ES. : Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ. 13(2) : 236-249, 2006.
58. Seshadri S, Duncan MD, Hart JM, Gavrilin MA, Wewers MD. : Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1beta processing and release. J Immunol. 179(2) : 1274-1281, 2007.
59. Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. : A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne : PAPA syndrome. Mayo Clin Proc. 72(7) : 611-6115, 2007.
60. Wise CA, Bennett LB, Pascual V, Gillum JD, Bowcock AM. : Localization of a gene for familial recurrent arthritis. Arthritis Rheum. 43(9) : 2041-2045, 2000.
61. Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M. : Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet. 11(8) : 961-969, 2002.
62. Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, Wise CA, Kastner DL. : Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA. 100(23) : 13501-13506, 2003.
63. Kinoshita T, Wang Y, Hasegawa M, Imamura R, Suda T. : PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. J Biol Chem. 280(23) : 21720-21725, 2005.
64. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, Bagga R, Kircheisen R, Ao A, Ratti B, Hanash S, Rouleau GA, Slim R. : Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 38(3) : 300-302, 2006.
65. Mor G. : Inflammation and pregnancy : the role of toll-like receptors in trophoblast-immune interaction. Ann N Y Acad Sci. 1127 : 121-128, 2008.
66. Murtha AP, Nieves A, Hauser ER, Swamy GK, Yonish BA, Sinclair TR, Heine RP. : Association of maternal IL-1 receptor antagonist intron 2 gene polymorphism and preterm birth. Am J Obstet Gynecol. 195(5) : 1249-1253, 2006.
67. Santtila S, Savinainen K, Hurme M. : Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 47(3) : 195-198, 1998.
68. Williams KL, Lich JD, Duncan JA, Reed W, Rallabhandi P, Moore C, Kurtz S, Coffield VM, Accavitti-Loper MA, Su L, Vogel SN, Braunstein M, Ting JP. : The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J Biol Chem. 280(48) : 39914-39924, 2005.
69. Ye Z, Lich JD, Moore CB, Duncan JA, Williams KL, Ting JP. ATP binding by monarch-1/NLRP12 is critical for its inhibitory function. Mol Cell Biol. 28(5) : 1841-1850, 2008.
70. Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, Taxman DJ, Ting JP. : Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J Immunol. 178(3) : 1256-1260, 2007.
71. Arthur JC, Lich JD, Aziz RK, Kotb M, Ting JP. : Heat shock protein 90 associates with monarch-1 and regulates its ability to promote degradation of NF-kappaB-inducing kinase. J Immunol. 179(9) : 6291-6296, 2007.
72. Wang L, Manji GA, Grenier JM, Al-Garawi A, Merriam S, Lora JM, Geddes BJ, Briskin M, DiStefano PS, Bertin J. : PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem. 277(33) : 29874-29880, 2002.
73. Jéru I, Duquesnoy P, Fernandes-Alnemri T, Cochet E, Yu JW, Lackmy-Port-Lis M, Grimprel E, Landman-Parker J, Hentgen V, Marlin S, McElreavey K, Sarkisian T, Grateau G, Alnemri ES, Amselem S. : Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci USA. 105(5) : 1614-1619, 2008.
74. Jéru I, Le Borgne G, Cochet E, Hayrapetyan H, Duquesnoy P, Grateau G, Morali A, Sarkisian T, Amselem S. : Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes. Arthritis Rheum. 63(5) : 1459-1464, 2011.
75. Strober W, Murray PJ, Kitani A, Watanabe T. : Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol. 6(1) : 9-20, 2006.
76. Hisamatsu T, Suzuki M, Podolsky DK. : Interferon-gamma augments CARD4/NOD1 gene and protein expression through interferon regulatory factor-1 in intestinal epithelial cells. J Biol Chem. 278(35) : 32962-32968, 2003.
77. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. : Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 276(7) : 4812-4818, 2001.
78. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Núñez G, Inohara N. : A critical role of RIP2/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J. 27(2) : 373-383, 2008.
79. Bertrand MJ, Doiron K, Labbé K, Korneluk RG, Barker PA, Saleh M. : Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity. 30(6) : 789-801, 2009.
80. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Häfner R, Chamaillard M, Zouali H, Thomas G, Hugot JP. : CARD15 mutations in Blau syndrome. Nat Genet. 29(1) : 19-20, 2001.
81. Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, Nakajima M, Kobayashi H, Fujiwara I, Tsutsumi H, Utani A, Nishigori C, Heike T, Nakahata T, Miyachi Y. : Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation : common genetic etiology with Blau syndrome. Blood. 105(3) : 1195-1197, 2005.
82. Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, Saito M, Yoshioka T, Kawai T, Sakai H, Tanizaki H, Heike T, Miyachi Y, Nakahata T. : Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 60(1) : 242-250, 2009.
83. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. : Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411(6837) : 599-603, 2001.
84. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH. : A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411(6837) : 603-606, 2001.
85. Lesage S, Zouali H, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group; EPIMAD Group; GETAID Group. : CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 70(4) : 845-857, 2002.
86. Watanabe T, Asano N, Murray PJ, Ozato K, Tailor P, Fuss IJ, Kitani A, Strober W. : Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest. 118(2) : 545-559, 2008.
87. Poeck H, Bscheider M, Gross O, Finger K, Roth S, Rebsamen M, Hannesschläger N, Schlee M, Rothenfusser S, Barchet W, Kato H, Akira S, Inoue S, Endres S, Peschel C, Hartmann G, Hornung V, Ruland J. : Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol. 11(1) : 63-69, 2010.
88. Maelfait J, Vercammen E, Janssens S, Schotte P, Haegman M, Magez S, Beyaert R. : Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J Exp Med. 205(9) : 1967-1973, 2008.
89. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA. : AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 458(7237) : 514-518, 2009.
90. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. : AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature. 458(7237) : 509-513, 2009.
91. Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, Planyavsky M, Bilban M, Colinge J, Bennett KL, Superti-Furga G. : An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol. 10(3) : 266-272, 2009.